The Board of Directors and the Chief Executive Officer of
For more information on
Derek Simmross, CEO,
E-mail: info@odipharma.com
ODI Pharma, based on its European network, subsidiaries and affiliates, is a producer and representative of finished pharmaceutical cannabis and cosmetics products with a focus on distribution to the medical cannabis market in Europe through its subsidiary ODI Pharma Polska Sp. z o.o. ODI Pharma intends to provide a high-quality product at a competitive price compared to competitors in Poland, thereby becoming the number one provider of medical cannabis in Poland. ODI Pharma also strives to be on the forefront of understanding the medical applications of the product as well as introducing new, innovative products to the European patients in need. The Company will continue to team up with the most knowledgeable and best renown partners in the industry to achieve its goals.
https://news.cision.com/odi-pharma/r/odi-pharma-ab-publishes-the-annual-report-for-the-fiscal-year-2022-2023,c3882540
https://mb.cision.com/Main/19043/3882540/2453666.pdf
(c) 2023 Cision. All rights reserved., source